20-33659970-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031232.4(NECAB3):āc.558G>Cā(p.Arg186Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,564,466 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_031232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152144Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000149 AC: 25AN: 168344Hom.: 0 AF XY: 0.000153 AC XY: 14AN XY: 91708
GnomAD4 exome AF: 0.000177 AC: 250AN: 1412322Hom.: 2 Cov.: 33 AF XY: 0.000173 AC XY: 121AN XY: 698662
GnomAD4 genome AF: 0.000145 AC: 22AN: 152144Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 30, 2024 | The c.558G>C (p.R186S) alteration is located in exon 7 (coding exon 7) of the NECAB3 gene. This alteration results from a G to C substitution at nucleotide position 558, causing the arginine (R) at amino acid position 186 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at